Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-01-30FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Par Health USA, LLC)
FDA approved a supplemental application for the olanzapine and fluoxetine combination (olanzapine + fluoxetine) submitted by Par Health USA,…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Enhancing Rehabilitation for Veterans With Serious Mental Illness [NA]
A VA-sponsored clinical trial aims to enhance rehabilitation for veterans with serious mental illness and related conditions. It is currentl…
-
FDA approval · 2026-01-28FDA Approved: DIVALPROEX SODIUM — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for divalproex sodium submitted by BluePoint Laboratories.
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Project CARE: An Integrated Treatment Adherence Program for Bipolar Disorder at the Time of Prison Release - Pilot RCT [NA]
Pilot randomized controlled trial evaluating Project CARE, an integrated treatment adherence program for bipolar disorder at the time of pri…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Project CARE: An Integrated Treatment Adherence Program for Bipolar Disorder at the Time of Prison Release - Open Trial [NA]
This clinical trial update reports completion and results posting for Project CARE, an integrated treatment adherence program for bipolar di…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Early Intervention for Youth at High Risk for Bipolar Disorder [NA]
A University of Pittsburgh–sponsored clinical trial update for an early intervention study in youth at high risk for bipolar disorder, curre…
-
CLINICAL_TRIALS withdrawal · 2026-01-28Clinical Trial Update: Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department [Phase 4]
A Phase 4 pilot trial of BXCL501 (sublingual dexmedetomidine) for agitation in the emergency department, including schizophrenia-spectrum an…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Psychiatric Genotype/Phenotype Project Repository
Clinical trial update from Vanderbilt University describing a psychiatric genotype/phenotype project repository. The study is currently enro…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Ketogenic Intervention for Bipolar Depression [NA]
A Mayo Clinic-initiated clinical trial is investigating a ketogenic intervention for bipolar depression and is currently recruiting particip…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder [Phase 2]
An ongoing Phase 2 clinical trial at McLean Hospital is evaluating the efficacy and safety of magnesium with vitamin B6 for individuals with…
-
EMA approval · 2026-01-23EMA Authorised: Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen) (aripiprazole) — Mylan Pharmaceuticals Limited
EMA authorised Aripiprazole Mylan Pharma (generic aripiprazole) for schizophrenia and bipolar disorder.
-
FDA approval · 2026-01-22FDA Approved: OLANZAPINE — Supplemental Application (Modavar Pharmaceuticals LLC)
The FDA approved Modavar Pharmaceuticals LLC's supplemental application to market a generic olanzapine product.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure [Phase 3]
This Phase 3 clinical trial is recruiting to test intensified pharmacological treatment for schizophrenia, major depressive disorder, and bi…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9) [Phase 4]
This clinical trial update describes a Phase 4 study comparing lithium and cariprazine for the acute treatment of bipolar depression, curren…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: fMRI of Flight of Ideas in Bipolar Disorder [NA]
Clinical trial using functional MRI to study flight of ideas in Bipolar Disorder has completed.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Study of ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolar Disorder in Adults [Phase 2]
A Phase 2 clinical trial update for ABX-002 as an adjunctive treatment for depressive episodes in adults with bipolar disorder, currently re…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Effects of Theta Burst Stimulation on the Brain, Behavior, and Clinical Symptoms in Adults With Bipolar Disorder [NA]
Completed clinical trial evaluating theta burst stimulation for brain activity, behavior, and clinical symptoms in adults with bipolar disor…
-
FDA approval · 2026-01-16FDA Approved: RYKINDO EXTENDED-RELEASE MICROSPHERES — Supplemental Application (Shandong Luye Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for RyKindo Extended-Release Microspheres, a new extended-release formulation of risperidone develop…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia [Phase 4]
Phase 4 study evaluating valbenazine for tardive dyskinesia in participants with schizophrenia, schizoaffective disorder, bipolar disorder, …
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Bipolar Disorder Integrative Staging: Incorporating Biomarkers Into Progression Across Stages
This clinical trial explores integrating biomarkers to stage bipolar disorder progression across stages. It is currently active but not recr…
-
FDA approval · 2026-01-14FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for a fixed-dose combination of olanzapine and fluoxetine, enabling generic marketing of the pr…
-
FDA approval · 2026-01-14FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for a fixed-dose combination of olanzapine and fluoxetine, adding its use for depressive episod…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Healthy Lifestyles in Bipolar Disorder: Bay Area Study [NA]
An ongoing Bay Area clinical trial investigating healthy lifestyle interventions for bipolar disorder, including time-restricted eating. Rec…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder [NA]
This clinical trial update concerns a multimodal intervention to support hospital-to-community transition in individuals with bipolar disord…
-
FDA approval · 2026-01-13FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Par Health USA, LLC)
FDA approved a supplemental application for the generic combination of olanzapine and fluoxetine, manufactured by Par Health USA, LLC.